With new data about different aspects of schizophrenia being continually generated, it
becomes necessary to periodically revisit exactly what we know. Along with a need to review …

Outcomes of psychotic disorders are associated with high personal, familiar, societal and
clinical burden. There is thus an urgent clinical and societal need for improving those …

Objective: The present guidelines address the pharmacotherapy of schizophrenia in adults
across different stages, phases, and symptom domains. Method: Guidelines were developed …

Some people who experience substance-induced psychosis later develop an enduring
psychotic disorder such as schizophrenia. This study examines the proportion of people with …

Abstract Background Brief Limited Intermittent Psychotic Symptoms (BLIPS) are key
inclusion criteria to define individuals at ultra high risk for psychosis (UHR). Their diagnostic …

Background In recent years, automated analyses using novel NLP methods have been used
to investigate language abnormalities in schizophrenia. In contrast, only a few studies used …

The heterogeneity in recovery outcomes for individuals with First Episode Psychosis (FEP)
calls for a strong evidence base to inform practice at an individual level. Between 19–89% of …

Background Obesity is highly prevalent in schizophrenia, with implications for psychiatric
prognosis, possibly through links between obesity and brain structure. In this longitudinal …

Brief psychotic episodes represent an intriguing paradox in clinical psychiatry because they
elude the standard knowledge that applies to the persisting psychotic disorders such as …

Introduction Obesity and dyslipidemia may negatively affect brain health and are frequent
medical comorbidities of schizophrenia and related disorders. Despite the high burden of …